BioHealth News Archive

Navigating the Challenges of Cell-Based Immunotherapies

Navigating the Challenges of Cell-Based Immunotherapies

Cell therapy is emerging, cell by cell, into the repertoire of medical therapies. However, it still has not broken into mainstream use. For instance,…

Read More
TEDCO Generates $1.6 Billion in Economic Benefits to the State of Maryland and Supports 7,746 Maryland Jobs, According to New Independent Study | TEDCO

TEDCO Generates $1.6 Billion in Economic Benefits to the State of Maryland and Supports 7,746 Maryland Jobs, According to New Independent Study | TEDCO

The Maryland Technology Development Corporation (TEDCO), Maryland’s economic engine for technology companies, announced today the findings of an independent economic impact study detailing the…

Read More
Rare disease racers speak out, stand tall at Racefor7 events in the U.S. and India

Rare disease racers speak out, stand tall at Racefor7 events in the U.S. and India

Visibility, speaking out, courage and organization. Forty years ago, these were the things that brought the Orphan Drug Act to life. On Sunday, February…

Read More
Be Bold. Cutting-edge Lab Space Available at the Gateway of the NIH. Delivering Summer 2021.

Be Bold. Cutting-edge Lab Space Available at the Gateway of the NIH. Delivering Summer 2021.

Cutting Edge Lab Space Available The NIH is the cornerstone to the world scientific community and is the largest life sciences engine in the…

Read More
These 3 tech investors are the most active in the DMV: report – Technical.ly DC

These 3 tech investors are the most active in the DMV: report – Technical.ly DC

Three investment firms topped the list of local tech investors in the DMV region according to CB Insights‘ report, The United States of Venture…

Read More
London HIV patient becomes second worldwide in remission, giving hope – Business Insider

London HIV patient becomes second worldwide in remission, giving hope – Business Insider

An HIV-positive man in Britain has become the second known adult worldwide to be cleared of the AIDS virus after he received a bone…

Read More
Behrman Capital Makes Significant Investment in Emmes

Behrman Capital Makes Significant Investment in Emmes

Emmes today announced that Behrman Capital, a leading private equity firm, has made a significant investment in the company.  The capital will allow Emmes,…

Read More
BHI Entrepreneur-in-Residence Feedback Session – March 20th

BHI Entrepreneur-in-Residence Feedback Session – March 20th

Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan?  Sign up by…

Read More
Strong interest in Non-Dilutive Funding Programs

Strong interest in Non-Dilutive Funding Programs

More than 120 people registered for last week’s SBIR Workshop organized by BioHealth Innovation in partnership with Launch Workplaces and support from TEDCO and…

Read More
State Department awards Emergent BioSolutions contract for chemical warfare countermeasures – Homeland Preparedness News

State Department awards Emergent BioSolutions contract for chemical warfare countermeasures – Homeland Preparedness News

Emergent BioSolutions announced today that the company has signed a deal with the U.S. Department of State to establish a supply chain for certain…

Read More
NEA is raising its biggest fund ever – – again – TechCrunch

NEA is raising its biggest fund ever – – again – TechCrunch

New Enterprise Associates, the 41-year-old venture firm with offices in Menlo Park; San Francisco; Boston; New York; Chevy Chase, Md.; and Washington, D.C., is…

Read More
Alexandria RE Equities Launches ‘GradLabs’ Product in San Diego | GlobeSt

Alexandria RE Equities Launches ‘GradLabs’ Product in San Diego | GlobeSt

Office REIT Alexandria Real Estate Equities reports it has launched a new product geared to providing post-seed-stage life science companies with turnkey, fully furnished…

Read More
MaxCyte Announces Multi-Drug Clinical & Commercial Agreement with Kite, a Gilead Company

MaxCyte Announces Multi-Drug Clinical & Commercial Agreement with Kite, a Gilead Company

MaxCyte, the global cell-based medicines and life sciences company, announced today that it has expanded its relationship with Kite, a Gilead Company, by entering…

Read More
A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready

A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready

Francis deSouza Photographer: Jeff Spicer/PA Wire via AP For years, the cost to decode a full human genome has been falling much like computer…

Read More
Gilead’s Kite pens 10-target CAR-T tech deal with MaxCyte – FierceBiotech

Gilead’s Kite pens 10-target CAR-T tech deal with MaxCyte – FierceBiotech

Gilead’s Kite Pharma has expanded its CAR-T agreement with MaxCyte. The revised deal gives Kite the chance to apply MaxCyte’s transfection technology to up…

Read More